ProfileGDS4132 / 238190_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 30% 31% 34% 38% 32% 31% 29% 33% 31% 29% 36% 41% 35% 42% 32% 40% 38% 45% 42% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10174.921830
GSM201543Muscle PCOS pioglitazone 12167.049631
GSM201544Muscle PCOS pioglitazone 16188.749934
GSM201545Muscle PCOS pioglitazone 201104.89538
GSM201829Muscle PCOS pioglitazone 23184.560332
GSM201830Muscle PCOS pioglitazon 25179.948531
GSM201831Muscle PCOS pioglitazone 27169.268829
GSM201832Muscle PCOS pioglitazone 3183.875433
GSM201833Muscle PCOS pioglitazone 4171.086131
GSM201834Muscle PCOS pioglitazone 8168.769929
GSM201835Muscle PCOS after pioglitazone 10276.383636
GSM201836Muscle PCOS after pioglitazone 12295.640541
GSM201837Muscle PCOS after pioglitazone 16275.093735
GSM201838Muscle PCOS after pioglitazone 20299.261142
GSM201839Muscle PCOS after pioglitazone 23272.36632
GSM201840Muscle PCOS after pioglitazone 25298.461140
GSM201841Muscle PCOS after pioglitazone 27282.982638
GSM201842Muscle PCOS after pioglitazone 3296.649645
GSM201843Muscle PCOS after pioglitazone 42104.46542
GSM201844Muscle PCOS after pioglitazone 8296.261439